Scinai Immunotherapeutics (SCNI) Current Leases (2019 - 2026)

Scinai Immunotherapeutics has disclosed Current Leases across 8 years of filings, most recently posting $369000.0 for Q2 2026.

• In Q2 2026, Current Leases fell 25.75% year-over-year to $369000.0; the TTM figure through Jun 2026 stood at $369000.0 (down 25.75% YoY), while the FY2025 annual figure was $329000.0, down 22.41% from the prior year.
• Current Leases came in at $369000.0 for Q2 2026 at Scinai Immunotherapeutics, up from $354000.0 in the prior quarter.
• In the past five years, Current Leases ranged from a high of $497000.0 in Q2 2025 to a low of $245000.0 in Q2 2022.
• Average Current Leases over 5 years is $364066.7, with a median of $369000.0 recorded in 2026.
• Year-over-year, Current Leases plunged 67.93% in 2022 and soared 60.82% in 2023.
• Over 5 years, Current Leases stood at $382000.0 in 2022, then climbed by 3.66% to $396000.0 in 2023, then climbed by 7.07% to $424000.0 in 2024, then retreated by 22.41% to $329000.0 in 2025, then climbed by 12.16% to $369000.0 in 2026.
• Per Business Quant data, the three most recent Current Leases figures were $369000.0 in Q2 2026, $354000.0 in Q1 2026, and $329000.0 in Q4 2025.